(R)-GSK-3685032

Modify Date: 2024-01-14 13:08:37

(R)-GSK-3685032 Structure
(R)-GSK-3685032 structure
Common Name (R)-GSK-3685032
CAS Number 2170140-50-6 Molecular Weight 420.53
Density N/A Boiling Point N/A
Molecular Formula C22H24N6OS Melting Point N/A
MSDS N/A Flash Point N/A

 Use of (R)-GSK-3685032


(R)-GSK-3685032 is the R-enantiomer of GSK-3685032. GSK-3685032 is a non-time-dependent, noncovalently, first-in-class reversible DNMT1-selective inhibitor, with an IC50 of 0.036 μM. GSK-3685032 induces robust loss of DNA methylation, transcriptional activation, and cancer cell growth inhibition[1][2].

 Names

Name (R)-GSK-3685032

 (R)-GSK-3685032 Biological Activity

Description (R)-GSK-3685032 is the R-enantiomer of GSK-3685032. GSK-3685032 is a non-time-dependent, noncovalently, first-in-class reversible DNMT1-selective inhibitor, with an IC50 of 0.036 μM. GSK-3685032 induces robust loss of DNA methylation, transcriptional activation, and cancer cell growth inhibition[1][2].
Related Catalog
Target

DNMT1

References

[1]. Substituted pyridines as inhibitors of DNMT1 and their preparation. WO2017216727.

[2]. Pappalardi MB, et al. Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia. Nat Cancer. 2021;2(10):1002-1017.

 Chemical & Physical Properties

Molecular Formula C22H24N6OS
Molecular Weight 420.53